Perceptions and Experiences of Xylazine, Disparities in Xylazine Awareness, and Correlates of Xylazine-Attributed Wounds Among People Who Use Opioids
Carl A. Latkin(Johns Hopkins University), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Ananya Bhaktaram(Johns Hopkins University), Lauren I. Dayton(Johns Hopkins University), Melissa A. Davey-Rothwell(Johns Hopkins University), Haley Bonneau(Johns Hopkins University), Danielle German(Johns Hopkins University)
International Journal of Environmental Research and Public Health
January 2, 2026
Cited by 0
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
|Mycoses|2011|159
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review
|UNC Libraries|2020|111
Understanding and addressing hepatitis C reinfection in the oral direct‐acting antiviral era
|Journal of Viral Hepatitis|2018|104